Abdominal Stent Graft- Market Insights, Competitive Landscape, and Market Forecast - 2030

Abdominal Stent Graft- Market Insights, Competitive Landscape, and Market Forecast - 2030

Abdominal Stent Graft Market By Material Type (Metal And Polymer), End-User (Hospitals, Ambulatory Surgical Centers, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) are expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of abdominal aortic aneurysm (AAA) and cardiac diseases, and increase in product launches and approvals across the globe.

The global abdominal stent graft market is estimated to grow at a CAGR of 4.31% during the forecast period from 2024 to 2030. The demand for abdominal stent grafts is primarily being boosted by the growing prevalence of abdominal aortic aneurysms and other related issues such as atherosclerosis. Furthermore, rising prevalence of cardiac disease due to smoking, obesity, and high blood pressure as these complications are significant risk factors for the development and progression of abdominal aortic aneurysms (AAAs) are also propelling the growth of the market. Additionally, large number of product approvals, and product launches are some of other key drivers that are responsible for contributing to the positive growth of the abdominal stent graft market during the forecast period from 2024 to 2030.

Abdominal Stent Graft Market Dynamics:

According to the estimates of DelveInsight the total diagnosed prevalent population of abdominal aortic aneurysm (AAA) in 7MM was estimated to be 1,641,380 cases in 2021. This anticipated surge in AAA cases is likely to drive the demand for abdominal stent-grafts, as they are essential medical devices used for treating abdominal aortic aneurysms thereby boosting the future market of the abdominal stent graft.

Additionally, as per the study published under National Library of Medicine (2021), “Obesity and obesity-induced inflammatory disease contribute to atherosclerosis,” states that obesity significantly increases the risk of atherosclerotic cardiovascular disease. Each one-point rise in BMI above normal weight correlates with a 10% increase in atherosclerosis and coronary heart disease risk. Additionally, as per the same source, 10 kg increase in body weight elevates the risk of atherosclerotic coronary artery disease by 12%. According to data provided by the World Health Organization (WHO) 2024, it was stated that in 2022, 2.5 billion adults aged 18 and older were overweight globally. Among these, 890 million were living with obesity, accounting for 16% of all adults. Thus, due to increase in obesity, the demand for abdominal stent grafts rises as obesity fosters the formation and accumulation of atherosclerotic plaque within arterial walls, necessitating intervention.

Furthermore, the increase in the various product approvals has played a major role in improving the overall market trends of abdominal stent grafts. For instance, in January 2023, MicroPort Scientific Corporation obtained approval from the Ministry of Food and Drug Safety of Korea for its Minos® Abdominal Aortic Stent-Graft and Delivery System. Thus, the increasing number of product approvals will eventually fuel the growth of the abdominal stent graft during the forecast period.

However, the risk of pre-operative and post-operative complications and lack of long-term outcome benefits in abdominal stent grafts may hinder the market demand of abdominal stent grafts.

Abdominal Stent Graft Market Segment Analysis:

Abdominal Stent Graft Market by Material Type (Metal and Polymer), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the abdominal stent graft market, the metal abdominal stent graft is estimated to have a significant revenue share in the abdominal stent graft market in 2023. This can be attributed to the various advantages and applications provided by the metal abdominal stent graft. Metal abdominal stent grafts offer advantages over polymer ones due to their greater durability, flexibility, and radial force. Metal stents provide better support for the vessel wall, reducing the risk of migration and endoleaks. Additionally, metal stents can be more easily repositioned during deployment and offer improved visibility under imaging, facilitating precise placement. Furthermore, metal stent-grafts typically have a lower profile, making them suitable for patients with tortuous anatomy.

Moreover, the rising product launches will also contribute to the growth of the metal abdominal stent grafts devices market thereby boosting the overall market of abdominal stent grafts. For instance, in September 2023, MicroPort Scientific Corporation, received approval from the Thailand Food and Drug Administration for Endovastec™ for its Castor™ Branched Aortic Stent-Graft and Delivery System, Minos™ Abdominal Aortic Stent-Graft and Delivery System, and Hercules™ Thoracic Stent Graft System with Low Profile Delivery System.

Hence, all the factors mentioned above are promoting the overall market growth of abdominal stent graft during the forecast period.

North America Is Expected To Dominate The Overall Abdominal Stent Graft Market:

North America is expected to account for the highest proportion of the abdominal stent graft market in 2023, out of all regions. This domination is due to the increasing cases of abdominal aortic aneurysms, cardiac disease due to smoking, and high blood pressure. Additionally, presence of robust research and development initiatives, increasing regulatory approvals and product launch activities are expected to aid in the growth of the North America abdominal stent grafts devices market during the forecast period of 2024 to 2030.

According to the Penn Medicine Lancaster General Health 2022, approximately 200,000 people in the United States are diagnosed with abdominal aortic aneurysms (AAA) annually. Those who are male and aged 65 or older, or who have a history of smoking, are at a heightened risk for developing AAA.

Additionally as per the latest data provided by Centre for Disease Control and Prevention (CDC) 2021, a history of smoking accounts for about 75% of all abdominal aortic aneurysms in the United States. Abdominal aortic aneurysms prevalence is four times higher in smokers than in non-smokers. Hence, the concurrent rise in AAA cases due to increasing smoking rates is driving the expansion of the abdominal stent graft market within the region.

Another factor responsible for the growth of the abdominal stent grafts devices market is the rising regulatory product approvals of innovative devices. For instance, on May 11, 2021, Endologix LLC announced the launch and first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval from Health Canada. Additionally, in May 2020, Terumo Aortic announced the US Food and Drug Administration (FDA) approval of the TREO™ Abdominal Aortic Stent-Graft System for sale in the United States for the treatment of patients with abdominal aortic aneurysms (AAA).

Thus, increasing product approval and product launches in the North American market may drive the product demand in the market, thus leading to the growth of the abdominal stent grafts devices market in North America.

Abdominal Stent Graft Market Key Players:

Some of the key market players operating in the abdominal stent graft include Endologix LLC., Medtronic, Terumo Aortic, MicroPort Scientific Corporation, Cook Medical, Cordis, JOTEC GmbH, W. L. Gore & Associates, Inc., Lombard Medical, Lifetech Scientific, SB-Kawasumi Laboratories, Inc., Endospan, Cardinal Health, Artivion Inc., Latecba SA, Nectero Medical, Cardiatis SA, Hangzhou Endonom Medtech Co., Ltd., and others.

Recent Developmental Activities In The Abdominal Stent Graft Market:

In October 2022, Endologix LLC disclosed the publication of the ELEVATE IDE Study in the Journal of Vascular Surgery, detailing the clinical outcomes of the ALTO Abdominal Stent Graft System. The study underscores the device's safety and efficacy one year after the procedure.

In September 2020, Terumo Corporation launched TREO™ Abdominal Aortic Stent-Graft System for the treatment of patients with abdominal aortic aneurysms (AAA) in the United States.

Key Takeaways From The Abdominal Stent Graft Market Report Study

Market size analysis for current abdominal stent graft Market size (2023), and market forecast for 6 years (2024 to 2030).

Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years.

Key companies dominating the global abdominal stent graft market.

Various opportunities available for the other competitors in the abdominal stent graft market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current abdominal stent graft market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for abdominal stent graft market growth in the coming future?

Target Audience Who Can Be Benefited From This Abdominal Stent Graft Market Report Study

Abdominal stent graft product providers.

Research organizations and consulting companies.

Abdominal stent graft-related organizations, associations, forums, and other alliances.

Government and corporate offices.

Start-up companies, venture capitalists, and private equity firms.

Distributors and Traders dealing in abdominal stent graft.

Various end-users who want to know more about the abdominal stent graft market and the latest technological developments in the abdominal stent graft market.

Frequently Asked Questions For The Abdominal Stent Graft Market:

1. What are abdominal stent grafts?

Abdominal stent grafts are medical devices used in the treatment of abdominal aortic aneurysms (AAA), which are weakened areas in the wall of the abdominal aorta. These devices are designed to reinforce and repair the weakened area of the aorta by providing support and sealing off the aneurysm to prevent its rupture.

2. What is the market for abdominal stent grafts?

The global abdominal stent graft market is estimated to grow at a CAGR of 4.31% during the forecast period from 2024 to 2030.

3. What are the drivers for the global abdominal stent graft market?

The demand for abdominal stent grafts is primarily being boosted by the growing prevalence of abdominal aortic aneurysms and other related issues such as atherosclerosis. Furthermore, the market for abdominal stent grafts is boosted by the rising prevalence of cardiac disease due to smoking, obesity, and high blood pressure as these complications are significant risk factors for the development and progression of abdominal aortic aneurysms. Additionally, the abdominal stent graft market is anticipated to grow on account of increasing number of product approvals, and product launches.

4. Who are the key players operating in the global abdominal stent graft market?

Some of the key market players operating in the abdominal stent graft include Endologix LLC., Medtronic, Terumo Aortic, MicroPort Scientific Corporation, Cook Medical, Cordis, JOTEC GmbH, W. L. Gore & Associates, Inc., Lombard Medical, Lifetech Scientific, SB-Kawasumi Laboratories, Inc., Endospan, Cardinal Health, Artivion Inc., Latecba SA, Nectero Medical, Cardiatis SA, Hangzhou Endonom Medtech Co., Ltd., and others.

5. Which region has the highest share in the global abdominal stent graft market?

North America is expected to account for the highest proportion of the abdominal stent graft market in 2023, out of all regions. This domination is due to the increasing cases of abdominal aortic aneurysms, cardiac disease due to smoking, and high blood pressure. Additionally, presence of robust research and development initiatives, increasing regulatory approvals and product launch activities are expected to aid in the growth of the North America abdominal stent grafts devices market during the forecast period of 2024 to 2030.